Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
letter
. 2010 Feb 12;33(3):E25–E29. doi: 10.1002/clc.20353

Underuse of Thrombolytic Therapy in Acute Myocardial Infarction and Left Bundle Branch Block

R Andrew Archbold 1,2,, Kulasegarum Ranjadayalan 1, Abdel Suliman 1, Charles J Knight 2,3, Andrew Deaner 2,3, Adam D Timmis 1,2
PMCID: PMC6653558  PMID: 20155857

Abstract

Thrombolytic therapy reduces mortality in patients with acute myocardial infarction (AMI) and left bundle branch block (LBBB). The difficulty in accurately diagnosing AMI in patients with LBBB, however, might result in their undertreatment. Among 3,890 patients hospitalized with chest pain, 241 (6.2%) had LBBB at presentation. The only variable independently associated with AMI among patients with LBBB was in‐hospital left ventricular failure (odds ratio [OR]: 4.32, 95% confidence interval [CI]: 1.95–9.57, p < 0.0005). Only 16 (29%) of the LBBB patients with AMI received thrombolytic therapy compared with 583 (78%) of the 747 patients with ST‐elevation AMI (p < 0.0005). A further 19 (10%) LBBB patients without AMI also received thrombolysis. Difficulty in making an accurate early diagnosis in patients with LBBB ensures that the majority of those with AMI fail to receive thrombolytic therapy while others without AMI are treated inappropriately. Improved diagnostic and therapeutic strategies are needed for patients with acute coronary syndromes and LBBB. Copyright © 2010 Wiley Periodicals, Inc.

Keywords: thrombolytic therapy, acute myocardial infarction, left bundle branch block

Full Text

The Full Text of this article is available as a PDF (97.4 KB).

References

  • 1. Sgarbossa EB, Pinski SL, Topol EJ, Califf RM, Barbagelata A, et al, for the GUSTO‐I (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators: Acute myocardial infarction and complete bundle branch block at hospital admission: Clinical characteristics and outcome in the thrombolytic era. J Am Coll Cardiol 1998; 31: 105–110. [DOI] [PubMed] [Google Scholar]
  • 2. Archbold RA, Sayer JW, Ray S, Wilkinson P, Ranjadayalan K, et al.: Frequency and prognostic implications of conduction defects in acute myocardial infarction since the introduction of thrombolytic therapy. Eur Heart J 1998; 19: 893–898. [DOI] [PubMed] [Google Scholar]
  • 3.Fibrinolytic Therapy Trialists (FFT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322. [PubMed] [Google Scholar]
  • 4. Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, et al, for the GUSTO‐I (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators: Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block. N Engl J Med 1996; 334: 481–487. [DOI] [PubMed] [Google Scholar]
  • 5. Shlipak MG, Lyons WL, Go AS, Chou TM, Evans GT, et al.: Should the electrocardiogram be used to guide therapy for patients with left bundle‐branch block and suspected myocardial infarction? JAMA 1999; 281: 714–719. [DOI] [PubMed] [Google Scholar]
  • 6. Gunnarsson G, Eriksson P, Dellborg M: ECG criteria in diagnosis of acute myocardial infarction in the presence of left bundle branch block. Int J Cardiol 2001; 78: 167–174. [DOI] [PubMed] [Google Scholar]
  • 7. Wong CK, French JK, Aylward PEG, Stewart RAH, Gao W, et al, for the HERO‐2 Trial Investigators: Patients with prolonged ischemic chest pain and presumed‐new left bundle branch block have heterogenous outcomes depending on the presence of ST‐segment changes. J Am Coll Cardiol 2005; 46: 29–38. [DOI] [PubMed] [Google Scholar]
  • 8. Go AS, Barron HV, Rundle AC, Omato JP, Avins AL, for the National Registry of Myocardial Infarction 2 Investigators: Bundle branch block and in‐hospital mortality in acute myocardial infarction. Ann Intern Med 1998; 129: 690–697. [DOI] [PubMed] [Google Scholar]
  • 9. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, et al.: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the management of Patients With Acute Myocardial Infarction). 2004. Available at www.acc.org/qualityandscience/ clinical/guidelines/stemi/STEMI%20Full%20Text.pdf (Accessed November 16, 2007).
  • 10. Knight CJ, Keeble TR, Wilson S, Cooper J, Deaner A, et al.: Short‐term prognosis of patients with acute coronary syndromes: The level of cardiac troponin T elevation corresponding to the “old” WHO definition of myocardial infarction. Heart 2005; 91: 373–374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Ammann P, Pfisterer M, Fehr T, Rickli H: Raised cardiac troponins. BMJ 2004; 328: 1028–1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Ludman P: British Cardiovascular Intervention Society audit returns 2006; Available at www.bcis.org.uk/resources/audit/ audit_2006 (Accessed November 11, 2007).

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES